What's new? Log in Free sign up

Industry / Biotechnology

Trending Companies

Companies in the news

Novo Nordisk A/S

What the Options Market Tells Us About Novo Nordisk

Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows

Morgan Stanley Reinstates Equal-Weight on Genmab, Announces $31 Price Target

BioMarin Pharmaceutical

FDA Battles Backlog of Drug Factory Inspections Since COVID-19

Reported Earlier, Vaxcyte Prices $1.3B Public Offering Of 10,194,175 Common Shares And Pre-Funded Warrants At $103/Share

Jazz Pharmaceuticals

FDA Accepts AXSM's NDA Resubmission for Migraine Drug, Stock Up

BridgeBio Pharma

Piper Sandler Initiates Coverage On BridgeBio Pharma with Overweight Rating, Announces Price Target of $46

Axsome Therapeutics

FDA Accepts AXSM's NDA Resubmission for Migraine Drug, Stock Up

Pulsario Enterprise

Latest filings

All filings

BioCardia / INTRACOASTAL CAPITAL ownership change

XRTX XORTX Therapeutics

XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders

AKTX Akari Therapeutics

Shelf registration

TNXP Tonix Pharmaceuticals Holding

AKTX Akari Therapeutics

Consolidated Financial Statements

Shelf registration

ELAB Elevai Labs, Inc. Common Stock

IPO registration

Cost Associated with Exit or Disposal Activities

GANX Gain Therapeutics

Prospectus supplement for primary offering

CNTB Connect Biopharma Holdings Limited

Current report (foreign)

Upcoming Earnings Releases

Earnings calendar

BioMarin Pharmaceutical

Novo Nordisk A/S

Aptose Biosciences

Enveric Biosciences

VolitionRx Limited

Latest IPO Filings (S1/F1/S11)

IPO calendar

ZBIO Zenas BioPharma

BIOA BioAge Labs

CDT Conduit Pharmaceuticals

ENVB Enveric Biosciences

WENA Anew Medical

GOVX GeoVax Labs

GOVX GeoVax Labs

ELAB Elevai Labs, Inc. Common Stock

Zenas BioPharma

Stock splits Upcoming and recent stock splits

Splits calendar

Tonix Pharmaceuticals Holding

60 Degrees Pharmaceuticals

Monopar Therapeutics

Aligos Therapeutics

Cadrenal Therapeutics, Inc. Common Stock

Ginkgo Bioworks

News

From Benzinga Pro

FDA Accepts AXSM's NDA Resubmission for Migraine Drug, Stock Up

'U.S. Prepares For Possible Arrival Of More Severe Strain Of Mpox; There Have Been Nearly 25,000 Cases Of The Clade 1 Version Of Mpox In Africa So Far This Year" - NBC

Leadership Shake-Ups In Cannabis And Psychedelics: Maryland's Cannabis Chief Resigns, Costly Legal Battle In MA Drags On & More

Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows

What the Options Market Tells Us About Novo Nordisk

FDA Battles Backlog of Drug Factory Inspections Since COVID-19

JMP Securities Reiterates Market Outperform on Vor Biopharma, Maintains $12 Price Target

Cantor Fitzgerald Reiterates Overweight on Skye Bioscience, Maintains $14 Price Target

Cantor Fitzgerald Reiterates Overweight on Axsome Therapeutics, Maintains $107 Price Target

What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday?

Press releases

From Benzinga Pro

XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders

Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN)

Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering

Vaxcyte Announces Closing of $1.5 Billion Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September

Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment

SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment

Psyence Biomed Announces the Signing of a Conditional Binding Term Sheet for the Acquisition of Psilocybin-Based Drug Developer Clairvoyant

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Transcripts

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Patents

GHB Formulation and Method for Its Manufacture

Cryopreserved Endothelial Cell Compositions

Systems and Methods to Aid Clinical Decision Support for Anti-inflammatory and Pro-resolving Therapies for Cardiovascular Disease

System and Method for Residual Cancer Cell Detection

Bifunctional Degraders of Hematopoietic Progenitor Kinase and Therapeutic Uses Thereof

Cryogenic System Connector

Devices, Methods and Systems for Sampling and Analyzing the Gastrointestinal Tract

Modified Peptide Fragments of CAV-1 Protein and the Use Thereof In the Treatment of Fibrosis

Cleavable Conjugates of Catechol Compounds and Water-soluble Polymers and Methods of Treatment Using the Same

Methods of Assigning a COVID Pathological Type and Compositions for Practicing the Same, and Methods of Treating a Subject for Chronic COVID-19

Reddit threads

Should Corporations like Pepsi be banned from suing poor people for growing food?

fluentinfinance

Why People Here Overlook International Stocks?

VOR - Will be moving higher

Sen. Elizabeth Warren writes a letter backing the DOJ investigation into Nvidia antitrust allegations

Expectations Vs Reality

fluentinfinance

Daily Discussion Thread - September 6th, 2024

LLY is beating out TSLA to become a Trillion Dollar company

SunHydrogen Asset Light business model appeals

RedChip TV Highlights OS Therapies (NYSE American: OSTX) & Can-Fite BioPharma (NYSE American: CANF)

WallStreetbetsELITE

Daily Discussion Thread - September 5th, 2024

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.